OBJECTIVE: To describe pharmacological preference for the treatment of neurobehavioural sequela of traumatic brain injury (TBI). DESIGN: Survey. PARTICIPANTS: TBI physiatrists were divided into specialists (completed a TBI fellowship or commit >70% of clinical practice time to TBI) and non-specialists. OUTCOME MEASURES: Participants were asked to list the drugs most frequently prescribed for each of 15 neurobehavioural symptoms commonly encountered during TBI rehabilitation and enumerate neurobehavioural symptom for which they prescribed each listed drug or drug class. RESULTS: There was no clear consensus on drug of choice for each target symptom. There were differences in drug choice patterns between specialists and non-specialists, especially for agitation. CONCLUSION: There is limited uniformity in drug selection for various TBI neurobehavioural sequela. Potential explanations include the availability of various medications with similar clinical effect, the variability of clinical presentation and severity of neurobehavioural symptoms and the lack of clinical practice guidelines.
OBJECTIVE: To describe pharmacological preference for the treatment of neurobehavioural sequela of traumatic brain injury (TBI). DESIGN: Survey. PARTICIPANTS: TBI physiatrists were divided into specialists (completed a TBI fellowship or commit >70% of clinical practice time to TBI) and non-specialists. OUTCOME MEASURES: Participants were asked to list the drugs most frequently prescribed for each of 15 neurobehavioural symptoms commonly encountered during TBI rehabilitation and enumerate neurobehavioural symptom for which they prescribed each listed drug or drug class. RESULTS: There was no clear consensus on drug of choice for each target symptom. There were differences in drug choice patterns between specialists and non-specialists, especially for agitation. CONCLUSION: There is limited uniformity in drug selection for various TBI neurobehavioural sequela. Potential explanations include the availability of various medications with similar clinical effect, the variability of clinical presentation and severity of neurobehavioural symptoms and the lack of clinical practice guidelines.
Authors: Suzanne Bock; Rod Grim; Todd F Barron; Andrew Wagenheim; Yaowen Eliot Hu; Matthew Hendell; John Deitch; Ellen Deibert Journal: Childs Nerv Syst Date: 2015-08-05 Impact factor: 1.475
Authors: Flora M Hammond; Ryan S Barrett; Timothy Shea; Ronald T Seel; Thomas W McAlister; Darryl Kaelin; David K Ryser; John D Corrigan; Nora Cullen; Susan D Horn Journal: Arch Phys Med Rehabil Date: 2015-08 Impact factor: 3.966
Authors: David R Williamson; Anne Julie Frenette; Lisa Burry; Marc M Perreault; Emmanuel Charbonney; François Lamontagne; Marie-Julie Potvin; Jean-François Giguère; Sangeeta Mehta; Francis Bernard Journal: Syst Rev Date: 2016-11-17
Authors: Theodore A Henderson; Muriel J van Lierop; Mary McLean; John Michael Uszler; John F Thornton; Yin-Hui Siow; Dan G Pavel; Joe Cardaci; Phil Cohen Journal: Front Psychiatry Date: 2020-04-15 Impact factor: 4.157
Authors: Flora M Hammond; Mark Sherer; James F Malec; Ross D Zafonte; Sureyya Dikmen; Jennifer Bogner; Kathleen R Bell; Jason Barber; Nancy Temkin Journal: J Neurotrauma Date: 2018-06-07 Impact factor: 5.269